These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 16371515)

  • 41. Impact of the extended thrombolysis time window on the proportion of recombinant tissue-type plasminogen activator-treated stroke patients and on door-to-needle time.
    Minnerup J; Wersching H; Ringelstein EB; Schilling M; Schäbitz WR; Wellmann J; Berger K
    Stroke; 2011 Oct; 42(10):2838-43. PubMed ID: 21852612
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systemic thrombolysis in patients with acute ischemic stroke and Internal Carotid ARtery Occlusion: the ICARO study.
    Paciaroni M; Balucani C; Agnelli G; Caso V; Silvestrelli G; Grotta JC; Demchuk AM; Sohn SI; Orlandi G; Leys D; Pezzini A; Alexandrov AV; Silvestrini M; Fofi L; Barlinn K; Inzitari D; Ferrarese C; Tassi R; Tsivgoulis G; Consoli D; Baldi A; Bovi P; Luda E; Galletti G; Invernizzi P; DeLodovici ML; Corea F; Del Sette M; Monaco S; Marcheselli S; Alberti A; Venti M; Acciarresi M; D'Amore C; Macellari F; Lanari A; Previdi P; Gonzales NR; Pandurengan RK; Vahidy FS; Sline M; Bal SS; Chiti A; Gialdini G; Dumont F; Cordonnier C; Debette S; Padovani A; Cerqua R; Bodechtel U; Kepplinger J; Nesi M; Nencini P; Beretta S; Trentini C; Martini G; Piperidou C; Heliopoulos I; D'Anna S; Cappellari M; Donati E; Bono G; Traverso E; Toni D
    Stroke; 2012 Jan; 43(1):125-30. PubMed ID: 22034003
    [TBL] [Abstract][Full Text] [Related]  

  • 43. THRIVE score predicts ischemic stroke outcomes and thrombolytic hemorrhage risk in VISTA.
    Flint AC; Faigeles BS; Cullen SP; Kamel H; Rao VA; Gupta R; Smith WS; Bath PM; Donnan GA;
    Stroke; 2013 Dec; 44(12):3365-9. PubMed ID: 24072004
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current status of intravenous thrombolysis for acute ischemic stroke in Asia.
    Sharma VK; Ng KW; Venketasubramanian N; Saqqur M; Teoh HL; Kaul S; Srivastava PM; Sergentanis T; Suwanwela N; Nguyen TH; Lawrence Wong KS; Chan BP
    Int J Stroke; 2011 Dec; 6(6):523-30. PubMed ID: 22111797
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tissue plasminogen activator overdose in acute ischemic stroke patients linked to poorer functional outcomes.
    Sahlas DJ; Gould L; Swartz RH; Mohammed N; McNicoll-Whiteman R; Naufal F; Oczkowski W
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):155-9. PubMed ID: 23375748
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exclusion of Isolated Cortical Swelling Can Increase Efficacy of Baseline Alberta Stroke Program Early CT Score in the Prediction of Prognosis in Acute Ischemic Stroke Patients Treated with Thrombolysis.
    Naito T; Takeuchi S; Arai N
    J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2754-8. PubMed ID: 26460245
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: the ICARO-2 study.
    Paciaroni M; Agnelli G; Caso V; Pieroni A; Bovi P; Cappellari M; Zini A; Nichelli P; Inzitari D; Nesi M; Nencini P; Pezzini A; Padovani A; Tassinari T; Orlandi G; Chiti A; Gialdini G; Alberti A; Venti M; Acciarresi M; D'Amore C; Luda E; Tassi R; Martini G; Ferrarese C; Beretta S; Trentini C; Silvestrelli G; Lanari A; Previdi P; Ciccone A; Delodovici ML; Bono G; Galletti G; Marcheselli S; Del Sette M; Traverso E; Riva M; Silvestrini M; Cerqua R; Consoli D; Monaco S; Toni D
    Cerebrovasc Dis; 2012; 34(5-6):430-5. PubMed ID: 23207482
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of arterial occlusion on outcome after intravenous thrombolysis for acute ischemic stroke.
    Medlin F; Amiguet M; Vanacker P; Michel P
    Stroke; 2015 Jan; 46(1):126-31. PubMed ID: 25424477
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of time to treatment on outcome in very elderly thrombolysed stroke patients.
    Frank B; Fulton RL; Lees KR;
    Int J Stroke; 2014 Jul; 9(5):591-6. PubMed ID: 24588833
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety of off-label stroke treatment with tissue plasminogen activator.
    Kvistad CE; Logallo N; Thomassen L; Waje-Andreassen U; Brøgger J; Naess H
    Acta Neurol Scand; 2013 Jul; 128(1):48-53. PubMed ID: 23311439
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Outcomes in mild acute ischemic stroke treated with intravenous thrombolysis: a retrospective analysis of the Get With the Guidelines-Stroke registry.
    Romano JG; Smith EE; Liang L; Gardener H; Camp S; Shuey L; Cook A; Campo-Bustillo I; Khatri P; Bhatt DL; Fonarow GC; Sacco RL; Schwamm LH
    JAMA Neurol; 2015 Apr; 72(4):423-31. PubMed ID: 25642650
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Racial differences in mortality among patients with acute ischemic stroke: an observational study.
    Xian Y; Holloway RG; Noyes K; Shah MN; Friedman B
    Ann Intern Med; 2011 Feb; 154(3):152-9. PubMed ID: 21282694
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is there a decreased risk of intracerebral hemorrhage and mortality in obese patients treated with intravenous thrombolysis in acute ischemic stroke?
    Hassan AE; Chaudhry SA; Jani V; Grigoryan M; Khan AA; Adil MM; Qureshi AI
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):545-9. PubMed ID: 23453555
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical outcomes among stroke patients receiving tissue plasminogen activator therapy beyond the 3-hour time window.
    O'Brien EC; Rose KM; Patel MD; Murphy CV; Rosamond WD
    J Stroke Cerebrovasc Dis; 2012 Oct; 21(7):541-6. PubMed ID: 21236701
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outcomes of Thai patients with acute ischemic stroke after intravenous thrombolysis.
    Dharmasaroja PA; Dharmasaroja P; Muengtaweepongsa S
    J Neurol Sci; 2011 Jan; 300(1-2):74-7. PubMed ID: 20937509
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator.
    Xian Y; Federspiel JJ; Grau-Sepulveda M; Hernandez AF; Schwamm LH; Bhatt DL; Smith EE; Reeves MJ; Thomas L; Webb L; Bettger JP; Laskowitz DT; Fonarow GC; Peterson ED
    JAMA Neurol; 2016 Jan; 73(1):50-9. PubMed ID: 26551916
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Initial body temperature in ischemic stroke: nonpotentiation of tissue-type plasminogen activator benefit and inverse association with severity.
    Kim SH; Saver JL
    Stroke; 2015 Jan; 46(1):132-6. PubMed ID: 25424482
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Direct Mechanical Intervention Versus Combined Intravenous and Mechanical Intervention in Large Artery Anterior Circulation Stroke: A Matched-Pairs Analysis.
    Broeg-Morvay A; Mordasini P; Bernasconi C; Bühlmann M; Pult F; Arnold M; Schroth G; Jung S; Mattle HP; Gralla J; Fischer U
    Stroke; 2016 Apr; 47(4):1037-44. PubMed ID: 26906917
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group.
    Kwiatkowski TG; Libman RB; Frankel M; Tilley BC; Morgenstern LB; Lu M; Broderick JP; Lewandowski CA; Marler JR; Levine SR; Brott T
    N Engl J Med; 1999 Jun; 340(23):1781-7. PubMed ID: 10362821
    [TBL] [Abstract][Full Text] [Related]  

  • 60. United States trends in thrombolysis for older adults with acute ischemic stroke.
    George BP; Asemota AO; Dorsey ER; Haider AH; Smart BJ; Urrutia VC; Schneider EB
    Clin Neurol Neurosurg; 2015 Dec; 139():16-23. PubMed ID: 26363362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.